Delivery Order SPE2DB25D3012-SPE2DB25FWZDV
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $11,236.71 for TAGRISSO 80 mg tablets (30-count supply) on November 12, 2025, with an ultimate completion date of December 4, 2025. This competitively awarded, firm fixed-price delivery order represents no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. TAGRISSO is an oncology medication used in the treatment of certain lung cancers, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $31,923.21 to AmerisourceBergen Drug Corp for TAGRISSO 40 mg tablets (30-count packages) on September 9, 2025, with completion expected by September 30, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TAGRISSO is a prescription oncology medication, and this procurement supports the...
- The Defense Logistics Agency awarded a $31,892.74 delivery order to AmerisourceBergen Drug Corp for TAGRISSO (80 mg tablets, 30-count package) under a firm fixed-price contract type. The award was issued on September 17, 2025, with an ultimate completion date of October 8, 2025, and represents a competitively awarded non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order, leveraging its established...
- The Defense Logistics Agency awarded a $10,662.57 delivery order to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count units) on September 5, 2025, with an ultimate completion date of September 26, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. TAGRISSO is a targeted cancer therapy used in the treatment of non-small cell lung cancer, reflecting...
- The Defense Logistics Agency awarded a $67,420.26 delivery order to AmerisourceBergen Drug Corp for supply of TAGRISSO 80 MG tablets (30-count units) under a firm fixed-price contract. The award was made on November 18, 2025, with an ultimate completion date of December 10, 2025. This non-competitive delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $10,662.57 delivery order to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count) under a firm fixed-price contract with an ultimate completion date of November 12, 2025. This is a non-set-aside, competitively awarded delivery order that will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for the supply of TAGRISSO 80 mg tablets (30-count packaging) on July 29, 2025, with an ultimate completion date of August 19, 2025. The contract employs firm fixed-price pricing and was not issued under any set-aside designation, indicating competitive award through open competition. Performance of this delivery order is based at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $21,282.14 delivery order to AmerisourceBergen Drug Corp for the supply of TAGRISSO 40 mg tablets (30-count units) under a firm fixed-price contract. The award was made on September 19, 2025, with an ultimate completion date of October 10, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award, reflecting the contractor's capability to...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of TAGRISSO 80 mg tablets in a quantity of 30 units. This is a firm fixed-price contract with a ceiling value of $159,938.55 and an ultimate completion date of October 16, 2025. The contract is not set-aside and was competitively awarded to the prime contractor, whose corporate office is located in Conshohocken, Pennsylvania. TAGRISSO is a prescription...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of TAGRISSO 40 mg tablets (30-count packages) valued at $31,923.21. This firm fixed-price delivery order, issued on August 27, 2025, with completion scheduled for September 18, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWZDVDelivery Order
The Defense Logistics Agency awarded a $10,662.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of TAGRISSO 80 MG tablets (30-count) under a competitively awarded contract with no set-aside designation. The delivery order was awarded on August 12, 2025, with an ultimate completion date of September 3, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. TAGRISSO is a prescription oncology medication, and this delivery order represents a single-line item fulfillment within the company's established federal pharmaceutical supply framework. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement that extends through December 2026 and serves as the comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains a significant role in federal medical procurement and supplies a comprehensive range of pharmaceutical products and medical supplies to support Defense Health Agency and other government healthcare systems. The company consistently demonstrates its capability to fulfill federal medical supply requirements through open competition and maintains a diverse portfolio of brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 8/12/25 |